Amid a shortage of amoxicillin and penicillin — the two main antibiotics for strep infections, which rose in early 2023 — Pfizer said it has “limited supply and [an] impending stock out situation” for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results